Articles On Vectus Biosystems (ASX:VBS)

ASX ticks up 0.19% to end trading week flat Six of 11 sectors down, materials and financials lead gains Uranium stocks fire up once again   ASX trundles to flat finish The ASX has traded pretty much entirely sideways this week, neither ga...

ASX healthcare sector gains 1.99% in November while benchmark ASX 200 down 2.66% Mach7 rises 50% in November with health imaging stock outlining a growth strategy at its AGM  Island Pharmaceuticals rises after FDA confirms Galidesivir will...

ASX resists session lows of -0.53pc to close 0.02pc higher Info tech, energy, real estate lead gains Banks and finance stocks in retreat ASX recovers from session lows The ASX 200 started the day in the red and stayed there until the las...

ASX up +0.25% at lunch time, down -0.14% by trade end Info tech and banking stocks lead losses Broad rally in resource stocks, led by gold   Info tech plunge unwinds market gains The ASX wobbled through an uncertain morning but was lookin...

Morning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the ASX in early-doors trading. With the market opening at 10am sharp eastern time, the data is taken at 10.15am in the east, once trading kicks...

ASX closes down 17 points or 0.19pc Banks, info tech weigh heavy Broad market gains with 130 of 200 stocks moving higher Numbers don’t always tell the tale The ASX 200 fell 17 points or 0.19% today but performed much better than first ap...

ASX recovers from session lows of -0.91pc to fall -0.13pc Info tech, commodities weakness undercut market Banks, defensive sectors mount resistance ASX battens down the hatches It was looking like we were in for another 90-point routing...

ASX healthcare sector fell 4.83% in October and is down more than 19% YTD CSL shares fall more than 15% on October 28 after management trims FY26 guidance Nyrada surges 165% in October on board changes and progress in phase 2a trial    Wi...

ASX falls to two-week lows, down 0.96pc Healthcare, industrials, financials smashed by high inflation read Uranium and resource stocks stage recovery   ASX tumbles on CPI read but uranium rallies Any chance of an intraday recovery was put...

ASX drags as CSL and WTC wipe out $20 billion in market cap intraday Healthcare and info tech smashed by heavyweight losses Resources stocks under pressure as US-China trade deal takes shape   ASX hammered by big cap losses It was already...

ASX slides 13 points, down 0.15pc Energy gives up early gains, still positive as oil climbs 5pc Healthcare leads losses ASX closes week pretty much flat It’s been a defensive week for the ASX 200, coming off a hot gold rally and a record...

ASX bounces off lows of -0.5pc to add two points Energy, defensive sectors and resources fuel gains Gold back in favour, even as prices remain subdued   Resources stocks fuel recovery The ASX was cruising for a bruising today, down 0.5%...

ASX falls 73 points, sliding back below 9000 points Only three sectors marginally higher, XGD up 1.27pc Defence-related, energy and info tech stocks tumble   The ASX 200 couldn’t maintain much of its gains this week, giving up the fight j...

ASX closes up 1.03% to four-day high with strong performances in healthcare, materials and financials Gold hits another all-time high – of US$4211 per ounce Telix surges 16% after reporting robust September quarter revenue from its prostat...

After five months of consecutive gains, the ASX 200 fell 0.78% in September with nine of 11 sectors in the red Smaller companies performed strongly with the ASX Emerging Companies and ASX Small Ordinaries rising 13% and 3% respectively Emb...

The S&P ASX 200 Health Care index fell 13.21% in August as a tough reporting season weighed on sector CSL had its biggest ever one day fall on August 19, down 17% following softer FY25 results and restructure plans Despite the broader...

ASX up 1pc on broad market gains Strong movement in big banks, lift almost 2pc Profit taking in gold stocks drives All Ords Gold lower Investors devour the dip It was a story of swift recovery on the ASX 200 today as falling bond yields...

ASX plunges in worst performance since April All 11 sectors and every index lower Rising bond yields a core driver of market weakness A sea of red The ASX 200 has had its worst trading day since April’s Liberation Day, plunging a full 16...

ASX falls from record highs, down 0.57pc Broad sell off, with 7 sectors down Energy, info tech show some stirrings of life   Investors take profits, pushing ASX lower The ASX has tumbled from its lofty heights above 9000 points, retreatin...

The S&P ASX 200 Health Care index rose 9.05% in July with rotation into the sector gaining momentum  Lumos soared 170% in July after six-year exclusive deal valued at up to US$317 million with PHASE Scientific for distribution of Febri...

ASX surges 1.37pc, smashing through record to close at 8757 points All 11 sectors neon green, up between 2.47pc and 0.46pc Healthcare and resources stocks crank higher, leading gains DJ play it louder It was a raver of a party on the ASX...

The ASX 200 Health Care Index fell 1.05% in June and remains the worst performing sector YTD down 6.64% Morgans healthcare analyst Iain Wilkie said June likely saw some tax loss selling before EOFY  Amplia up 300% in June after complete re...

The S&P/ASX 200 Health Care Index rose 1.59% in May but remains worst performing sector YTD down 5.65% Morgans healthcare analyst Iain Wilkie said US President Donald Trump’s trade and health policies continue to impact sector Lumos up...

ASX slips 0.24pc in trade Falling oil prices drive energy and utilities stocks lower Gold ticks up, lifting ASX All Ords Gold Index 0.85pc   The ASX fell 0.24% during the session, experiencing broad weakness on the back of renewed tariff...

US Secretary of the Treasury Scott Bessent is expected to meet with senior Chinese officials on Thursday Oil price hike lifts Energy sector more than 2pc Healthcare weighs on market under tariff shadow, down more than 1pc   The ASX has bu...

The S&P/ASX 200 Health Care Index rose 2.16% in April with the S&P/ASX 200 rallying 3.6% Morgans healthcare analyst Iain Wilkie said April was a marked improvement on recent months Several approvals during April, including for EBR...

The S&P/ASX 200 Health Care Index fell 7.66% in February with the S&P/ASX 200 down 3.79% Morgans healthcare analyst Iain Wilkie said several factors caused investor jitters in February including job cuts to US FDA  Pacific Edge was...

The S&P/ASX 200 Health Care Index fell 1.85% in December but rose 7.51% overall in 2024  Mesoblast surged 52% in December after the US FDA approved its cell therapy Ryoncil for treatment of paediatric GvHD Percheron plunged 91% in Dece...

The S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Health cryogenic services company Vitrafy and nerve-repair biotech Renerve debuted on the ASX  Paradigm Biopharmaceuticals rose 151% in Novembe...

ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results Artrya and Nyrada make key clinical advances   The S&P/ASX 200 Health Care [XHJ] index was down 0.9% gain in October. For the year, th...

Healthcare stocks are doing relatively well globally in 2024
 The sector could see more recovery as Fed cuts rates
 How ASX biotechs performed in the month of September   The S&P 500 Health Care Index, a key world benchmark for health...

ASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing; sector outpaced benchmark 10x since 2006 AI is revolutionising healthcare, boosting diagnosis and treatment   The ASX Healthcare Index (AS...

S&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expected Fed rate cuts; ResMed seen as a strong buy And ASX healthcare winners and losers in July   The S&P/ASX 200 Health Care index [XHJ]...

The EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-listed company that collaborates with Eisai We take a look at the best performing ASX health stocks in the past month   In a major blow for...

The ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biotechs in June were Actinogen, Optiscan and EZZ Life Science, amongst others    The S&P/ASX 200 Health Care index [XHJ] saw a 4% increase...

S&P/ASX 200 rose 1% in June with large caps leading gains with mid, small and emerging companies lagging S&P/ASX 200 financials and consumer staples were the top performers in June with materials the biggest laggard Urea fertiliser...

ASX down 0.5pc, Energy sector up due mainly to Woodside’s upgrade. CRH to acquire Adbri, ending Adbri’s 62-year ASX presence China’s data CPI keeps increasing, new data shows   The ASX continued yesterday’s decline, down another -0.5% tod...

Aussie shares rise in arvo trade Resources sectors weigh, Real Estate adds 2pc GDP lowest in 40 years ex. COVID   The local bourse has come home with a sail wet on Wednesday with the ordinariness of our economy bringing market joy as it d...

 S&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biotech stocks We take a look at the ASX biotech winners for the month   The  S&P/ASX 200 Health Care [XHJ] closed flattish for the month o...

Research shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase the risk of dementia We look at the best performing ASX stocks over the past month    The phrase ‘you are what you eat’ was coined almost a c...

Tech stocks surged on ASX today, offset by losses in Mining stocks Gold and copper hit all-time highs Ethereum on the rise on rumours of ETF approvals in the US   The ASX 200 closed around -0.15% lower on Tuesday, as gains in Tech stocks...

ASX 200’s rally was driven mainly by gold/silver and iron ore stocks Gold prices hit record high as China continues to buy bullion Asian markets rose due to high commodity prices and new stimulus measures    The ASX 200 index rose by +0....

ASX Health sector was in correction territory in April Why is the health sector different from other sectors? We look at the best performing ASX health stocks for the month   The S&P/ASX 200 Health Care [XHJ] had a soft month in April...

There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month   Scientists have made a significant b...

The ASX200 closed +0.5% higher on Tuesday on the back of a big lift in the Mining sector.  Lithium stocks led, with IGO (ASX:IGO) and Pilbara (ASX:PLS) gaining around 3%.  Iron ore miners  rallied after the Nymex CFR China, 62% Fe price swu...

The ASX 200 traded sideways on Tuesday, closing the day flattish as gains in healthcare stocks were offset by losses in other sectors. Source: Market Index  Healthcare gained after the Albanese government approved an increase in private hea...

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

  ASX200 a victim of reflation fears, drops 0.4pc 5 sectors in the red, 3 led by Utilities are green and there’s three I’m calling as flat Small cap winners led by Alicanto Minerals   The ASX benchmark has had worse days, but just like so...

Xi and Biden set to agree on restricting fentanyl  Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks   China’s President Xi is expected...

News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks   Goldman Sachs analysts said they will make no...